According to the board of directors of international architecture and design firm Perkins Eastman, Steve Rosenstein has joined the firm as a principal in the New York office. He will lead the strategic development of Perkins Eastman's presence within the science and technology sector.
Rosenstein's 37 years of experience in the planning and design of technologically complex laboratories and research facilities comprise major projects throughout the United States and in 20 countries around the world for high-profile clients including Pfizer, Bristol Meyers Squibb, The Exxon Mobil Corporation, Unilever, Dupont, LG Pharmaceuticals, Colgate-Palmolive, the National Institutes of Health (NIH), the Environmental Protection Agency (EPA), and the Food and Drug Administration (FDA).

Rosenstein has also planned academic R&D facilities for The Johns Hopkins University, Mayo Clinic, Whitehead Institute, Cornell University, Pennsylvania State University, The University of California San Diego, and The University of Texas at San Antonio. His specialized expertise includes strategic space utilization planning, master planning, vivarium facilities planning, development of pilot plant and scale-up facilities, and adaptive reuse projects.
Perkins Eastman's chairman and CEO Bradford Perkins, FAIA said, "We have worked with Steve Rosenstein for more than 25 years, and are very pleased that he has joined us to expand our growing practice in science and technology projects both in the US and overseas."

Prior to joining Perkins Eastman, Rosenstein managed his own firm, Steven Rosenstein Associates (SRA). SRA has merged with Perkins Eastman and will provide additional capabilities and experience for the firm's extensive involvement in the design of science and technology driven facilities. Tags: